Voyager Therapeutics (VYGR) Gains from Investment Securities (2014 - 2015)
Voyager Therapeutics (VYGR) reported Gains from Investment Securities of $9.8 million for Q1 2015, up 4900.0% sequentially from $195000.0 in Q4 2014.
Voyager Therapeutics (VYGR) Gains from Investment Securities (2014 - 2015) Analysis & Trends
Voyager Therapeutics (VYGR) has 2 years of Gains from Investment Securities data on file, last reported at $9.8 million in Q1 2015.
- For the quarter ending Q1 2015, Gains from Investment Securities changed N/A year-over-year to $9.8 million; the trailing twelve-month figure through Dec 2015 stood at $9.8 million (changed N/A YoY), and the FY2016 full-year result was $9.8 million, up 0.51% from the prior year.
- Gains from Investment Securities rose to $9.8 million in Q1 2015, from $195000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $9.8 million in Q1 2015 to a low of $195000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 182.95 Mn | 41.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 9.75 Mn |
| Mar 31, 2015 | 9.75 Mn |
| Dec 31, 2014 | 195,000.00 |
| Dec 31, 2014 | 195,000.00 |